Federated Hermes, Inc. Bridge Bio Pharma, Inc. Call Options Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding BBIO
# of Institutions
332Shares Held
184MCall Options Held
13.5MPut Options Held
2.43M-
Viking Global Investors LP25.1MShares$960 Million2.33% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$736 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$569 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$476 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$274 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.67B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...